Current Concepts In Medicine Questions✅

INTERNAL MEDICINE: HEMATOLOGY

  • Acute Chest Syndrome (ACS) in Sickle Cell Disease:

    • Presentation: A patient with Sickle Cell Disease presenting with respiratory distress while receiving a blood transfusion develops sudden fever and chills.
    • Immediate Management: The most appropriate first action is to stop the transfusion to rule out or manage a transfusion reaction before addressing ACS protocols (e.g., hydroxyurea, hydration, or ABC management).
  • Aplastic Anemia Diagnostic Presentation:

    • Clinical Signs: 26-year-old female with progressive fatigue (22 months), purple skin blotches (petechiae) on the trunk and extremities.
    • Laboratory Findings:
      • Hemoglobin (Hb): 72 g/L72\,g/L (Low: Normal 120−160120-160)
      • Hematocrit (HCT): 0.220.22 (Low: Normal 0.37−0.480.37-0.48)
      • MCV: 92 fl92\,fl (Normocytic: Normal 80−9580-95)
      • WBC: 1.5×109/L1.5 \times 10^9/L (Leukopenia: Normal 4.5−10.54.5-10.5)
      • Platelets: 10×109/L10 \times 10^9/L (Thrombocytopenia: Normal 150−400150-400)
    • Diagnosis: Aplastic Anemia (characterized by pancytopenia with a normocytic RBC profile).
  • Beta Thalassemia Minor:

    • Clinical Presentation: Often asymptomatic or detected during pre-marital counseling.
    • Laboratory Profile:
      • Hb: 110 g/L110\,g/L
      • MCV: 67 fl67\,fl (Microcytic)
      • Hb A2\text{Hb } A_2: 4.5%4.5\% (Elevated: Normal <3.5%<3.5\%)
      • Sickling Test: Negative.
    • Diagnosis: Beta Thalassemia Minor (distinguished by elevated Hb A2\text{Hb } A_2 and microcytosis).
  • Polycythemia Rubra Vera:

    • Symptoms/Signs: Headaches, tiredness, febrile, palpable spleen tip.
    • Laboratory Labs:
      • Hb: 200 g/L200\,g/L (Significantly elevated: Normal 130−170130-170)
      • HCT: 0.670.67 (High: Normal 0.42−0.520.42-0.52)
      • WBC: 12×109/L12 \times 10^9/L (High: Normal 4.5−10.54.5-10.5)
      • Platelets: 420×109/L420 \times 10^9/L (Mild elevation)
      • Serum Erythropoietin (EPO): Very low levels.
  • Anemia of Chronic Disease (ACD):

    • Context: Patient with sarcoidosis presenting with mild pallor.
    • Laboratory Profile: Hb 100 g/L100\,g/L, HCT 0.290.29, MCV 79 fl79\,fl (Borderline microcytic/normocytic), WBC and Platelets normal.
    • Key Marker: Ferritin 915 ng/L915\,ng/L (High: Normal 22−56122-561).
    • Diagnosis: Anemia of Chronic Disease (ACD), common in chronic inflammatory conditions like sarcoidosis.
  • Antiphospholipid Syndrome (APS):

    • Markers: 35-year-old female with bilateral leg Deep Vein Thrombosis (DVT), a history of recurrent stillbirths, and an elevated APTT (55 sec55\,sec) which does not correct on mixing studies (paradoxical in vitro finding).
  • Thrombotic Thrombocytopenic Purpura (TTP):

    • Clinical Pentad Components: Fever (38.6∘C38.6^\circ C), headache, petechiae, anemia (Hb 11.2Hb \, 11.2), and profound thrombocytopenia (Platelets 32Platelets \, 32).
    • Laboratory Indicators:
      • MCV: 102 fl102\,fl
      • Reticulocytes: 4.9%4.9\%
      • Lactate Dehydrogenase (LDH): 690 IU/L690\,IU/L (High: Normal 60−16060-160 indicative of hemolysis)
      • Indirect Bilirubin: 43 umol/L43\,umol/L
      • Normal Coagulation: APTT (36 s36\,s), INR (1.11.1), PT (11 s11\,s) distinguish TTP from DIC.
  • Febrile Neutropenia Management:

    • Context: Patient on chemotherapy for Acute Lymphoblastic Leukemia (ALL) with WBC 0.60.6, platelets 2525, and fever (38.9∘C38.9^\circ C).
    • Action: Send blood, urine, and sputum cultures and start intravenous broad-spectrum antibiotics immediately.

NEPHROLOGY

  • Drug Safety in CKD Stage 3 (eGFR 30−59 mL/min/1.73 m230-59\,mL/min/1.73\,m^2):

    • Warfarin is generally considered safe for prescription in CKD Stage 3. Drugs like Nitrofurantoin, Metformin (risk of lactic acidosis), and Lithium require careful monitoring or discontinuation in advanced CKD.
  • Adult Polycystic Kidney Disease (ADPKD) Screening:

    • The most appropriate screening test for first-degree relatives of patients with ADPKD is an Abdominal Ultrasound.
  • UTI Management in Pregnancy:

    • Choice of Antibiotic: For a pregnant woman at 3838 weeks with dysuria/frequency (positive nitrites/leukocytes), Cefalexin is appropriate. Nitrofurantoin is avoided at term due to the risk of hemolytic anemia in the newborn (G6PD related).
  • Renal Artery Stenosis (RAS):

    • Indicators: Elderly patient with Ischemic Heart Disease, taking 44 antihypertensives (refractory HTN), and asymmetrical kidneys on abdominal ultrasound.
  • Uremic Neuropathy:

    • Presentation: CKD (33 years), numbness of hands/feet, decreased sensation to pinprick/vibration below the knee, and absent ankle reflexes. Labs show Urea 46 mmol/L46\,mmol/L and Creatinine 674 umol/L674\,umol/L.
    • Management: Initiation of dialysis is the definitive treatment for symptomatic uremia (neuropathy).
  • Hypercalciuria and Nephrolithiasis:

    • To reduce stone formation in patients with hypercalciuria, Thiazide diuretics are used as they increase calcium reabsorption in the distal tubule.
  • Contrast-Associated Acute Kidney Injury (CA-AKI) Prevention:

    • Effective Strategy: IV Isotonic saline before and after contrast administration in CKD Stage 3 (eGFR 42eGFR \, 42).
  • Granulomatosis with Polyangiitis (GPA):

    • Presentation: Pulmonary hemorrhage, rapidly progressive glomerulonephritis, history of sinusitis, and neurological deficits (numbness).
  • Acute Tubular Necrosis (ATN) Post-Contrast:

    • Mechanism: Rapid rise in Urea (30.430.4) and Creatinine (378378) shortly after intravenous contrast exposure.
  • Tumor Lysis Syndrome (TLS) - Readiness for Chemotherapy:

    • Criteria to Resume: Uric acid <475 umol/L<475\,umol/L, creatinine <141 umol/L<141\,umol/L, and pH≥7pH \ge 7.

ENDOCRINOLOGY

  • Primary Hyperaldosteronism (Conn's Syndrome):

    • Screening Context: Uncontrolled hypertension despite triple therapy (ramipril, atenolol, amlodipine) and persistent hypokalemia (2.9 mmol/L2.9\,mmol/L).
  • Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH):

    • Clinical Profile: Seizures, severe hyponatremia (112 mmol/L112\,mmol/L), low serum osmolality (240 mmol/kg240\,mmol/kg), and high urine osmolality (860 mOsm/kg860\,mOsm/kg) despite low plasma levels.
  • Diabetes Insipidus (DI):

    • Water Deprivation Test Interpretation:
      • Central DI: Serum osmolality high, urine fails to concentrate, but concentrates after desmopressin.
      • Nephrogenic DI: No concentration of urine despite desmopressin administration.
  • Thyrotoxicosis:

    • Labs: Extremely low TSH (0.01 U/L0.01\,U/L), high Free T4T_4 (30.4 pmol/L30.4\,pmol/L), and high Free T3T_3 (9.5 pmol/L9.5\,pmol/L).
  • Hypothyroidism Management:

    • Adjustment: If a patient on 0.025 mg0.025\,mg L-thyroxin remains symptomatic (fatigue, weight gain) with a high TSH (19.9 mU/L19.9\,mU/L), the correct action is to Increase L-thyroxin and check TSH in 6 weeks.
  • Prolactinoma:

    • Presentation: Man with galactorrhea, headache, low sexual interest, infertility, and Prolactin 2350 pmol/L2350\,pmol/L. Visual field defect: Bitemporal hemianopia due to compression of the optic chiasm.
    • Workup: Brain MRI is the diagnostic gold standard.
  • Diabetic Ketoacidosis (DKA) Management:

    • Insulin Protocol: Current standard for DKA involves Fixed-rate IV insulin infusion alongside continuation of long-acting (basal) insulin.
  • Acromegaly Surveillance:

    • Required future investigation after OGTT/MRI confirmation: Colonoscopy (due to increased risk of colonic polyps and cancer).
  • Type 2 Diabetes Mellitus (T2DM) Obesity Management:

    • First-line for BMI 3434, fasting glucose 99, and HbA1c \, 7.8\%$: **Dietary advice, exercise, and metformin**.\n\n# CARDIOLOGY\n\n* **Hyperthyroidism-related Palpitations:**\n * Management: **Propranolol** (Beta-blocker) is the most appropriate management for the symptomatic relief of palpitations and adrenergic overactivity in thyrotoxicosis.\n\n* **Hypertrophic Cardiomyopathy (HCM):**\n * Significance: Leading cause of sudden cardiac death in young athletes; requires exclusion if there is a family history of sudden death during physical activity.\n\n* **Warfarin Management (INR 7.0, No Bleeding):**\n * Action: **Hold warfarin and repeat INR the next day**. Administering Vitamin K may be considered depending on clinical guidelines, but increasing/continuing the dose is contraindicated.\n\n* **Acute Heart Failure (Decompensation):**\n * Immediate Management: IV loop diuretics like **Furosemide** to address pulmonary crackles, pitting edema, and orthopnea.\n\n* **Acute Lateral Myocardial Infarction:**\n * ECG: ST-elevation in Leads I, aVL, V5, V6.\n * Occluded Vessel: **Left Circumflex Artery (LCX)**.\n\n* **Aortic Dissection:**\n * Signs: Sudden tearing chest pain radiating to the back, blood pressure discrepancy between arms, absent femoral pulse.\n * Confirmation: **Aortic CT Angiography**.\n\n* **Endocarditis Monitoring:**\n * The simplest way to monitor the therapeutic response to antibiotics in infective endocarditis is serial **Serum C-reactive protein (CRP)** levels.\n\n* **Aortic Regurgitation Physical Signs:**\n * Collapsing pulse, wide pulse pressure (130/33 style), Early Diastolic Murmur, and Pistol-shot sounds over femoral arteries (Traube's sign).\n\n# NEUROLOGY\n\n* **Post-Stroke Management:**\n * A patient 10 days post-infarction already on lisinopril/HCTZ: The standard secondary prevention includes **Aspirin**.\n\n* **Transient Ischemic Attack (TIA) / Amaurosis Fugax:**\n * Clinical: Sudden, temporary eye visual loss (20 minutes) in a diabetic, returning to normal.\n\n* **Amyotrophic Lateral Sclerosis (ALS):**\n * Triad: Bulbar symptoms (dysphagia, tongue fasciculations), Upper Motor Neuron signs (brisk reflexes, spasticity), and Lower Motor Neuron signs (weakness, fasciculations).\n\n* **Multiple Sclerosis (MS) Acute Relapse:**\n * Treatment: **IV Methylprednisolone** for 3-5 days is the standard for acute relapses involving new lesions/ataxia/diplopia.\n\n* **Parkinson's Disease vs. Dementia:**\n * Diagnosis: A patient with cognitive decline associated with bradykinesia, resting tremors, mask-like facies, and shuffling gait is suggestive of **Parkinson's Disease Dementia** or Lewy Body Dementia.\n\n* **Autonomic Neuropathy:**\n * Sign: Orthostatic hypotension (drop from 140/85toto115/80 upon standing) in a long-standing diabetic.\n\n* **Hypercalcemia Management:**\n * Immediate Initial Treatment: **I.V. 0.9% Sodium Chloride** (rehydration) is the critical first step for severe hypercalcemia (3.41\,mmol/L).\n\n# RHEUMATOLOGY\n\n* **Biological Therapy Screening (Infliximab):**\n * Prior to starting anti-TNF agents like infliximab, mandatory screening includes **Chest X-ray and TB screening (IGRA or TST)**, regardless of childhood BCG vaccination.\n\n* **Neonatal Lupus:**\n * Autoantibody: **Anti-Ro (SSA)** is associated with congenital heart block in infants born to mothers with SLE.\n\n* **Drug-Induced Lupus (DIL) vs. SLE:**\n * DIL is typically characterized by high anti-histone antibodies and usually **lacks renal or CNS involvement**, whereas SLE frequently involves the kidneys.\n\n* **Lupus Nephritis Management:**\n * Context: SLE with proteinuria, RBC casts, high anti-dsDNA, and low C3/C4 levels.\n * Action: **Begin high-dose steroids and plan a renal biopsy**.\n\n* **ANCA-Associated Vasculitides:**\n * **GPA (Granulomatosis with Polyangiitis):** Nasal congestion/epistaxis, pulmonary nodules, hematuria, and **c-ANCA positive**.\n * **EGPA (Eosinophilic GPA):** Asthma, peripheral neuropathy (mononeuritis multiplex), eosinophilia, and **p-ANCA positive**.\n\n# GASTROENTEROLOGY (GIT)\n\n* **Crohn's Disease - Perianal Fistula:**\n * Initial management for a mild perianal fistula with minimal drainage and no abscess: **Oral Metronidazole**.\n\n* **Acute Severe Ulcerative Colitis:**\n * Presentation: >6$$ bloody stools/day, fever, abdominal pain.
    • Management: Admit for IV corticosteroids.